IRhythm Technologies PE Ratio 2015-2023 | IRTC
Current and historical p/e ratio for IRhythm Technologies (IRTC) from 2015 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. IRhythm Technologies PE ratio as of April 17, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| IRhythm Technologies PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-18 | 112.12 | 0.00 | |
| 2023-12-31 | 107.04 | $-4.05 | 0.00 |
| 2023-09-30 | 94.26 | $-3.46 | 0.00 |
| 2023-06-30 | 104.32 | $-3.28 | 0.00 |
| 2023-03-31 | 124.03 | $-3.47 | 0.00 |
| 2022-12-31 | 93.67 | $-3.89 | 0.00 |
| 2022-09-30 | 125.28 | $-4.32 | 0.00 |
| 2022-06-30 | 108.03 | $-4.42 | 0.00 |
| 2022-03-31 | 157.47 | $-4.21 | 0.00 |
| 2021-12-31 | 117.69 | $-3.45 | 0.00 |
| 2021-09-30 | 58.56 | $-2.68 | 0.00 |
| 2021-06-30 | 66.35 | $-2.04 | 0.00 |
| 2021-03-31 | 138.86 | $-2.20 | 0.00 |
| 2020-12-31 | 237.21 | $-1.59 | 0.00 |
| 2020-09-30 | 238.11 | $-1.91 | 0.00 |
| 2020-06-30 | 115.89 | $-2.48 | 0.00 |
| 2020-03-31 | 81.35 | $-2.19 | 0.00 |
| 2019-12-31 | 68.09 | $-2.18 | 0.00 |
| 2019-09-30 | 74.11 | $-2.14 | 0.00 |
| 2019-06-30 | 79.08 | $-1.83 | 0.00 |
| 2019-03-31 | 74.96 | $-1.88 | 0.00 |
| 2018-12-31 | 69.48 | $-2.02 | 0.00 |
| 2018-09-30 | 94.66 | $-1.89 | 0.00 |
| 2018-06-30 | 81.13 | $-1.75 | 0.00 |
| 2018-03-31 | 62.95 | $-1.53 | 0.00 |
| 2017-12-31 | 56.05 | $-1.30 | 0.00 |
| 2017-09-30 | 51.88 | $-1.19 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.470B | $0.493B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.875B | 21.62 |
| Inspire Medical Systems (INSP) | United States | $7.378B | 0.00 |
| 10x Genomics (TXG) | United States | $3.475B | 0.00 |
| Axonics (AXNX) | United States | $3.427B | 0.00 |
| Enovis (ENOV) | United States | $3.084B | 23.43 |
| Azenta (AZTA) | United States | $2.854B | 232.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.772B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.659B | 0.00 |
| Privia Health (PRVA) | United States | $2.118B | 93.95 |
| Schrodinger (SDGR) | United States | $1.811B | 0.00 |
| Phreesia (PHR) | United States | $1.306B | 0.00 |
| Omnicell (OMCL) | United States | $1.206B | 29.52 |
| Definitive Healthcare (DH) | United States | $0.847B | 0.00 |
| Standard BioTools (LAB) | United States | $0.757B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.497B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.329B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.316B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.308B | 0.00 |
| Pulmonx (LUNG) | United States | $0.286B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.171B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.158B | 0.00 |
| Augmedix (AUGX) | United States | $0.155B | 0.00 |
| American Well (AMWL) | United States | $0.149B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
| TruBridge (TBRG) | United States | $0.122B | 5.19 |
| Outset Medical (OM) | United States | $0.112B | 0.00 |
| 111 (YI) | China | $0.081B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.076B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| ETAO (ETAO) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| Akili (AKLI) | United States | $0.017B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |